Literature DB >> 16860182

Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytoma.

Susan Uthup1, Krishna Balachandran, Vimala Avadai Ammal, Riyas Abdul Salam, Jacob George, Geetha M Nair, Manju Leela.   

Abstract

A 47-year-old man presented with fever of unknown origin, generalized weakness, edema, and renal failure. He had left-sided pleural effusion, generalized lymphadenopathy, multiple nontender cutaneous nodules, hepatomegaly, renal failure, and hypergammaglobulinemia. Axillary lymph node biopsy showed findings consistent with Castleman disease of the hyaline vascular type associated with interfollicular plasmacytosis. A renal biopsy performed in view of proteinuria and acute renal failure showed hypercellular glomeruli with capillary loop thickening and double contours consistent with membranoproliferative glomerulonephritis. Skin nodule biopsy showed a glomeruloid hemangioma characterized by dermal proliferation of capillary loops in a nodular manner resembling a glomerulus. He experienced clinical and biochemical remission with steroids. Discontinuation of steroid therapy was associated with recurrence of renal failure, reappearance of nodules, lymphadenopathy, and appearance of bony lytic lesions. Biopsy of bony lytic lesions showed plasmacytoma. The patient achieved complete remission on treatment with steroids and cyclophosphamide and is free of symptoms at the end of 40 months of follow-up. To our knowledge, this is the first case report of the occurrence of membranoproliferative glomerulonephritis, glomeruloid hemangioma of the skin, and plasmacytoma in a patient with multicentric Castleman disease without human immunodeficiency virus infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860182     DOI: 10.1053/j.ajkd.2006.04.089

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome.

Authors:  Masatoshi Matsunami; Yoshifumi Ubara; Keiichi Sumida; Yoichi Oshima; Masahiko Oguro; Kazuya Kinoshita; Kiho Tanaka; Yuki Nakamura; Keiichi Kinowaki; Kenichi Ohashi; Takeshi Fujii; Takuro Igawa; Yasuharu Sato; Yasuo Ishii
Journal:  BMC Nephrol       Date:  2018-10-11       Impact factor: 2.388

2.  Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.

Authors:  Yuejuan Pan; Zhuan Cui; Song Wang; Danxia Zheng; Zhenling Deng; Xinyu Tian; Hongxia Guo; Wenhan Bao; Sijia Zhou; Yue Wang
Journal:  BMC Nephrol       Date:  2020-12-04       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.